Epidemiology and Infectious Diseases

Peer-review medical journal

Editor-in-chief

Founder

Publisher

About

Launch Year: 1996

The journal covers issues of diagnosis, treatment and prevention of infectious diseases.

Special attention is devoted to clinical analyses of diagnostically difficult cases, analysis of epidemics, new diagnostic and treatment methods, and epidemiological situation in Russia and the rest of the world. The journal publishes official documents issued by the Russian Ministry of Healthcare, Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, societies for infectiologists, epidemiologists, microbiologists and parasitologists as well as information on meetings, symposia, and conferences in Russia and the rest of the world.

The journal is aimed at a wide spectrum of researchers and practicing specialists focusing on diagnosis, treatment and prevention of infectious diseases: epidemiologists, infectiologists, microbiologists, primary care physicians, and family medicine specialists.

Indexation

  • Russian Science Citation Index (on WoS)
  • CrossRef
  • Google Scholar
  • Ulrich’s International Periodicals Directory
  • WorldCat

Types of accepted articles

  • plain reviews
  • systematic reviews and metaanalysis
  • results of original research (experimental, clinical, epidemiological
  • clinical cases and series of clinical cases
  • short communications
  • letters to the editor

Publications

  • regular issues bimonthly, 6 issues per year
  • articles — continuously online (Online First)
  • with NO APC (free of charge for all authors)
  • in Russian and English
  • in hybrid access mode — by subscription or in Open Access with CC BY-NC-ND 4.0 license  (authors are welcome for Optional Open Access (see more)

Current Issue

Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription Access

Vol 31, No 1 (2026)

Cover Page

Full Issue

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Original study articles

Antibacterial activity of pentosan polysulfate sodium against uropathogenic bacteria
Kraeva L.A., Smirnova E.V., Tokmalaev A.K., Slesarevskaya M.N., Kuzmin I.V.
Abstract

BACKGROUND: The primary causative agents of lower urinary tract infections are Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecalis. In recent years, these bacteria have demonstrated high levels of antibiotic resistance. The barrier function of the bladder mucosal epithelium is largely determined by the glycosaminoglycan layer, which protects the bladder wall from infectious agents. Disruption of this layer leads to inflammation, which may progress to painful bladder syndrome or cystitis. Pentosan polysulfate sodium is a semisynthetic glycosaminoglycan that is chemically and structurally similar to naturally occurring glycosaminoglycans. It restores the damaged urothelial layer and prevents contact between the bladder mucosal epithelium and various aggressive substances dissolved in urine.

AIM: This work aimed to investigate the in vitro antibacterial, antiadhesive, and antibiofilm activities of pentosan polysulfate sodium.

METHODS: Classical bacteriological methods, mass spectrometry, microscopy, an experimental adhesion model using buccal epithelial cells, and statistical data analysis were used. Study material was obtained from women aged 18 years and older with a history of cystitis lasting at least three years during disease exacerbation.

RESULTS: The antibacterial effect of pentosan polysulfate sodium during co-cultivation with the main pathogens of lower urinary tract infections persisted for up to 15 hours. The mechanism of antibacterial action was associated with the ability of pentosan polysulfate sodium to inhibit bacterial adhesion to the urothelium. The most pronounced antiadhesive effect was observed against E. faecalis: in the presence of pentosan polysulfate sodium, there was a 3.7-fold decrease in the number of bacteria adhered to buccal epithelial cells. The adhesion index decreased by 3.3-fold for E. coli and 2.6-fold for K. pneumoniae. Pentosan polysulfate sodium also demonstrated antibiofilm properties, reducing the density of biofilms formed by E. coli by 1.7-fold, E. faecalis by 1.6-fold, and K. pneumoniae by 1.2-fold. These findings confirm the potential of pentosan polysulfate sodium to enhance the effectiveness of therapy for lower urinary tract infections, particularly those associated with microbial biofilms.

CONCLUSION: This in vitro study made it possible to identify and quantitatively assess the antibacterial, antiadhesive, and antibiofilm activities of pentosan polysulfate sodium against uropathogenic microorganisms isolated from the urine of patients with recurrent lower urinary tract infections.

Epidemiology and Infectious Diseases. 2026;31(1):5-14
pages 5-14 views
A two-center nonrandomized retrospective study to assess the efficacy of hyperimmune globulin in the treatment of patients with COVID-19
Igityan T.A., Burgasova O.А., Tetova V.B., Ogarkova D.A., Tokmalaev A.K.
Abstract

BACKGROUND: Despite the availability of vaccines and antiviral drugs, there is still a need for effective therapeutic strategies for patients with COVID-19, especially those at high risk of severe disease. Hyperimmune globulin against COVID-19 is a promising immunologic agent. However, real-world data on its efficacy, particularly that on treatment timing, are limited and require further investigation.

AIM: This study aimed to evaluate the efficacy and safety of hyperimmune globulin (COVID-globulin) in the treatment of hospitalized patients with COVID-19 and to determine the optimal timing of its use.

METHODS: This was a retrospective, cohort study, conducted at 2 clinical sites in Moscow from January 1, 2022 to January 31, 2023. The study included 148 patients aged 20 to 94 years with confirmed SARS-CoV-2 infection. The main group (n = 88) comprised patients who received COVID-globulin in addition to standard therapy, whereas the comparison group (n = 60) comprised patients who received standard therapy alone. The primary efficacy endpoint was mortality in the compared groups by discharge (days 7–10 of hospitalization). The secondary endpoint included assessment of clinical parameters, laboratory and radiographic findings over time.

RESULTS: The overall mortality rate in the main group (8.0%) did not differ significantly from that in the control group (6.7%) at discharge (p = 1.000). However, a correlation was identified between the efficacy of COVID-globulin and the timing of its inclusion in the treatment regimen. Administration of the drug within the first 7 days of disease onset demonstrated relevant clinical advantages compared with later administration. It resulted in a significant reduction in the median length of hospitalization from 15 (IQR, 13.5–19) to 10 (IQR, 8–14) days (p < 0.001), improvement in SpO2 values (97% [96–98] vs. 95% [94–96]; p = 0.024), and a more pronounced decrease in C-reactive protein levels by discharge (8.1 mg/L [2–19] vs. 23 mg/L [19–43]; p = 0.023). In the main group, complete resolution of pulmonary infiltrative changes on computed tomography by the time of discharge was also observed significantly more frequently (56.5% vs. 10.5% in the control group; p < 0.001). No adverse events associated with drug administration were recorded.

CONCLUSION: The use of COVID-globulin in hospitalized patients with COVID-19 did not result in a significant reduction in mortality. However, we demonstrated significant efficacy of this therapeutic strategy when COVID-globulin was used during the first week of illness, as evidenced by a shorter duration of hospitalization, more rapid resolution of respiratory dysfunction, and resolution of inflammation.

Epidemiology and Infectious Diseases. 2026;31(1):15-28
pages 15-28 views
Analysis of antibiotic resistance of bacterial isolates from the lower respiratory tract in patients with community-acquired pneumonia
Khakimov N.M., Lokotkova A.I., Latypova L.F.
Abstract

BACKGROUND: Community-acquired pneumonia retains high socioeconomic and epidemiologic significance. Investigation of its etiology and antibiotic resistance patterns is of substantial practical importance, particularly in the context of the global epidemiologic threat associated with COVID-19.

AIM: This study aimed to study the etiologic structure and antibiotic resistance of bacteria isolated from the lower respiratory tract of patients with community-acquired pneumonia.

METHODS: This was a single-center, retrospective, uncontrolled study. Medical records of patients diagnosed with community-acquired pneumonia who were hospitalized in the Pulmonology Department of Kazan City Clinical Hospital from January 2018 to December 2021 were analyzed. Susceptibility of bacteria isolated from patients’ sputum to 19 antimicrobial agents was determined using the disk diffusion method.

RESULTS: A total of 282 medical records of patients aged 18–94 years were analyzed. Bacteria and their associations were isolated in 245 patients (86.9% ± 2.01%). In nearly half of the cases (47.9% ± 4.4%), sputum cultures contained Candida albicans, both as a monoculture and in association with bacterial flora. Streptococcus pyogenes was isolated from the sputum of every fifth patient (20.2% ± 5.4%), and Streptococcus pneumonia from every sixth patient (14.2% ± 5.6%). The detection rate of C. albicans was significantly higher than that of other isolates (p < 0.001). During the COVID-19 pandemic, the proportion of Candida albicans increased 1.36-fold in 2020 and 1.84-fold in 2021 compared with 2019. Before the pandemic, gram-positive bacteria predominated in the etiologic structure; however, beginning in 2020, a trend toward an increased proportion of gram-negative microflora was observed. The proportion of gram-negative bacteria increased from 7.14% ± 11.5% to 38.46% ± 21.8%, both in association with fungi and in monoculture. This increase was attributable to Enterobacter agglomerans and Klebsiella pneumoniae.

Analysis of the antimicrobial resistance of the isolated clinical strains demonstrated that a high level of resistance was predominantly characteristic of Gram-negative microorganisms, including Escherichia coli, K. pneumoniae, and E. agglomerans. In contrast, Gram-positive pathogens showed high susceptibility to β-lactams, macrolides, and trimethoprim-sulfamethoxazole. The severity of community-acquired pneumonia caused by bacterial associations did not differ from that observed in monoinfection (p > 0.05).

CONCLUSION: The COVID-19 pandemic substantially affected the etiologic structure of pathogens causing community-acquired pneumonia, increasing the role of Gram-negative bacteria and their associations with fungi. Among the identified Gram-negative pathogens, multidrug-resistant isolates predominated. The findings underscore the need for further microbiologic investigations and regular updates of clinical guidelines for the treatment of community-acquired pneumonia, taking into account the principles of rational antibiotic therapy.

Epidemiology and Infectious Diseases. 2026;31(1):29-40
pages 29-40 views

Reviews

Modern strategies for etiotropic therapy and prevention of respiratory syncytial virus infection
Mirolaev M.M., Burgasova O.А., Kruzhkova I.S., Burtseva E.I., Tokmalaev A.K.
Abstract

Respiratory syncytial virus remains one of the leading causes of lower respiratory tract infections worldwide and poses a serious threat to young children and older adults. This review aimed to analyze current strategies for the treatment and prevention of respiratory syncytial virus infection that have emerged as a result of fundamental advances in viral structural biology. The article reviews up-to-date epidemiological data, including changes in seasonality observed after the pandemic, as well as challenges in clinical diagnosis. It discusses evolution of passive immunoprophylaxis, and presents the results of studies evaluating the efficacy of novel recombinant vaccines for active immunization. Particular attention is paid to the assessment of promising agents for etiotropic therapy. The available evidence indicates that the introduction of new preventive and therapeutic interventions makes it possible to shift respiratory syncytial virus infection into the category of manageable diseases. An important future task is the establishment of continuous molecular epidemiological surveillance to monitor the potential development of viral resistance to existing therapeutic and preventive agents.

Epidemiology and Infectious Diseases. 2026;31(1):41-50
pages 41-50 views
Equal yet different: a comparative characterization of Ruthenibacterium lactatiformans and Faecalibacterium prausnitzii
Das M.S., Podoprigora I.V., Yashina N.V., Senyagin A.N., Tokmalaev A.K., Orlova V.S., Efimov B.A.
Abstract

The gut microbiota plays a key role in maintaining human homeostasis. Of particular interest are 2 bacterial species of the family Oscillospiraceae: the well-studied Faecalibacterium prausnitzii, with proven anti-inflammatory properties, and the recently described Ruthenibacterium lactatiformans, whose functional potential remains insufficiently investigated. Despite their phylogenetic proximity, these species differ substantially in metabolic properties, associations with pathological conditions, and probiotic potential. The work aimed to conduct a comparative analysis of the characteristics of F. prausnitzii and R. lactatiformans and their interactions with the host, as well as to summarize data on possible mechanisms underlying their influence on the development of a wide range of diseases, including inflammatory bowel diseases, cardiovascular, metabolic, neurologic, and oncologic diseases.

Studies demonstrate that reduced abundance of F. prausnitzii serves as a reliable biomarker of dysbiosis and is associated with chronic inflammatory, autoimmune, and metabolic diseases. The protective role of this bacterium is primarily related to butyrate production and immunomodulation. In contrast to F. prausnitzii, associations of R. lactatiformans with pathological conditions are inconsistent. Increased abundance of this species correlates with both pathological states (stroke, active multiple sclerosis) and periods of clinical remission in certain diseases. At the same time, in experimental models, R. lactatiformans demonstrates protective, particularly metabolic, properties.

The decrease in F. prausnitzii abundance under pathological conditions is likely explained by its sensitivity to environmental changes such as tissue acidosis and oxidative stress. In contrast, R. lactatiformans, owing to greater metabolic plasticity (ability to produce lactate and acetate) and relative aerotolerance, is capable of adapting to these unfavorable conditions.

In conclusion, we support the hypothesis that the observed changes may reflect a dynamic dysbiotic shift and potential synergism rather than competition: R. lactatiformans, acting as an adaptive substrate supplier, may contribute to restoration of conditions favorable for subsequent colonization by butyrate-producing bacteria such as F. prausnitzii. This opens new perspectives for the development of probiotic strategies based on synergistic bacterial consortia.

Epidemiology and Infectious Diseases. 2026;31(1):51-63
pages 51-63 views
In vitro and in vivo modeling of Vibrio cholerae biofilms
Titova S.V., Vodopyanov S.O., Menshikova E.A., Selyanskaya N.A.
Abstract

Studies of water bodies in India and Bangladesh have shown that removal of large particles from water reduces the incidence of cholera. Detection of aggregated communities of Vibrio cholerae (biofilms) provided evidence of their role in cholera epidemiology and stimulated investigation of biofilm forms. Summarizing available data in this field is particularly relevant because there are no unified methods for assessing biofilm formation and quantitatively determining the microorganisms comprising biofilms. The work aimed to evaluate methodological approaches to investigating biofilm formation by V. cholerae, focusing on their detection and reproducibility in laboratories of different levels.

Models (in vitro, in vivo, and microcosm), as well as methods for biofilm detection, were analyzed. Scopus, Web of Science, MEDLINE, the Russian Science Citation Index, and other sources were used to prepare the review. Data were searched using the following keywords: Vibrio cholerae, биоплёнка (biofilm), методы (methods), микроскопия (microscopy), микрокосмы (microcosms), молекулярно-генетические (molecular genetic). The review included 63 original articles, 3 review articles, and 1 monograph.

The review summarizes current concepts regarding the process of V. cholerae biofilm formation. Methods for modeling on abiotic and biotic substrates, including field conditions, approaches to biofilm detection, and the use of in vivo methods to assess infectivity of biofilm cultures, are described. Particular attention is paid to the role of molecular genetic methods. According to the published data, the most effective strategy for studying biofilm formation is an integrated approach combining microbiologic, microscopic, and molecular genetic methods. The review also addresses current challenges and promising research directions in this field.

The analysis of current issues and research prospects in V. cholerae biofilms, including recent molecular genetic methods, demonstrates that investigation of biofilms formed by vibrios using a range of methods will allow deeper understanding of the general principles of bacterial coexistence in communities. This, in turn, will contribute to more effective strategies for combating infections, including cholera.

Epidemiology and Infectious Diseases. 2026;31(1):64-75
pages 64-75 views

Retraction notices

Retraction of the article: Nosocomial infections: New vistas in their prevention (DOI: 10.17816/EID40498)
Abstract

The editorial board of the journal “Epidemiology and Infectious Diseases” announces the retraction of the article “Nosocomial infections: New vistas in their prevention “ published in 2011; 16(1) by Pokrovskiy VI, et al. (10.17816/EID40498 EDN: NDSHUN).

The reason for retraction is duplicate publication in another journal without the publishers’ consent. Similar article: Pokrovskiy VI, Akimkin VG, Briko NI, et al. Nosocomial infections: New vistas in their prevention. Public Health care. 2011;(1):14–20. EDN: QBKAHZ. The editors found the publication of a similar article while monitoring the journal’s scientometric indicators. It was not possible to reliably determine to which journal the article was first submitted using available methods. Therefore, a decision was made to retract the article from the journal “Epidemiology and Infectious Diseases”.

Epidemiology and Infectious Diseases. 2026;31(1):76-77
pages 76-77 views


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).